Logo image
IRO Home Research units Researcher Profiles
Sign in
Update on pharmacology of antiplatelets, anticoagulants, and thrombolytics
Journal article   Open access   Peer reviewed

Update on pharmacology of antiplatelets, anticoagulants, and thrombolytics

Esteban Cheng-Ching, Edgar A Samaniego, Bharath Reddy Naravetla, Osama O Zaidat and Muhammad Shazam Hussain
Neurology, Vol.79(13 Suppl 1), pp.S68-S76
09/25/2012
DOI: 10.1212/WNL.0b013e3182695871
PMID: 23008416
url
https://doi.org/10.1212/WNL.0b013e3182695871View
Published (Version of record) Open Access

Abstract

Understanding of the pharmacology of thrombolytics, anticoagulants, and antiplatelets is critical to performing safe and effective endovascular therapy for acute ischemic therapy. This is a basic review of the clinical pharmacologic data on the anticoagulants, antiplatelets, and fibrinolytic agents most commonly used in the treatment of stroke and in the neurointerventional suite.
Humans Anticoagulants - therapeutic use Stroke - drug therapy Stroke - pathology Fibrinolytic Agents - pharmacology Stroke - metabolism Animals Blood Platelets - metabolism Anticoagulants - pharmacology Fibrinolytic Agents - therapeutic use Thrombolytic Therapy - methods Platelet Aggregation Inhibitors - pharmacology Blood Platelets - drug effects Platelet Aggregation Inhibitors - therapeutic use Thrombolytic Therapy - trends

Details

Logo image